Brief: Brooks Laboratories Unit Gets UK Marketing Authorization For Meropenem Injection 1 GM And 500 Mg
May 23 (Reuters) - Brooks Laboratories Ltd BROO.NS :
* UNIT'S VADODARA FACILITY GETS MARKETING AUTHORIZATION IN
UK BY
MHRA FOR MEROPENEM INJECTION 1 GM AND 500 MG
Source text for Eikon: ID:nBSE9Msn0n
Further company coverage: BROO.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brooks Laboratories
See all newsBrief: Brooks Laboratories Says Board Approves Scheme Of Arrangement With Abridge Speciality
Brief: Brooks Laboratories Enters Binding MoU With Steriscience Specialties Pvt Ltd And Brooks Steriscience
Brief: Brooks Laboratories Appoints Prashant Rathi As CEO
Brief: Brooks Laboratories Names Prashant Rathi As CEO
Brief: Brooks Laboratories Approves Fund Raise Of Up To 750 Million Rupees